Saturday 10 October 2026
Export all INNV data to Excel Powerpack
InnovAge Holding Corp.
INNV Healthcare Medical Care Facilities
InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025. In the quarter to June 2026, revenue grew 18.3%, EPS grew 700.0%, free cash flow grew 85.4% and total debt fell 16.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
9.10
0.01
−0.11%
Follow INNV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 103.80 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.62 | 1.15 | 0.77 | 0.79 | |
P/FCF ratio |
31.73 | 25.40 | 15.20 | 21.38 | |
P/Operating CF |
75.53 | 60.00 | 32.97 | 178.30 | |
P/B ratio |
6.73 | 4.68 | 2.70 | 2.80 | |
Price to Tangible BV |
17.20 | 12.46 | 6.09 | 6.72 | |
EV/Sales |
1.54 | 1.07 | 0.70 | 0.74 | |
EV/EBITDA |
62.08 | 110.85 | 22.45 | 208.55 | |
EV/Operating CF |
23.53 | 19.33 | 10.90 | 14.80 | |
EV/FCF |
30.05 | 23.65 | 13.86 | 20.03 | |
Quick Ratio |
0.92 | 0.87 | 1.04 | 0.98 | |
Current Ratio |
1.05 | 1.03 | 1.26 | 1.17 | |
Net Debt/EBITDA |
(5.08) | 3.12 | (3.38) | (3.24) | |
Debt/Assets |
10.10% | 11.59% | 12.12% | 12.83% | |
Debt/Equity |
0.24 | 0.27 | 0.24 | 0.26 | |
Asset Turnover |
1.83 | 1.75 | 1.74 | 1.70 | |
Operating CF/Net income |
2.57 | (0.62) | 2.01 | 0.49 | |
Capex/Depreciation |
(0.65) | 0.02 | (0.47) | (0.77) | |
Interest Coverage |
13.13 | (29.43) | 10.64 | 6.63 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.42% | 33.85% | 14.47% | 16.04% | |
Intangible Assets out of Total Assets |
0.26 | 0.27 | 0.28 | 0.29 | |
Share Based Compensation of Revenue |
0.66% | 0.71% | 0.51% | 0.98% | |
Graham Net Nets |
(0.06) | (0.10) | (0.12) | (0.14) | |
Graham Number |
0.00 | 0.00 | 1.47 | 0.00 | |
Earnings Yield |
(0.17%) | (1.12%) | 0.96% | (2.52%) | |
Free Cash Flow Yield |
3.15% | 3.94% | 6.58% | 4.68% | |
Revenue per Share |
1.93 | 1.86 | 1.77 | 1.74 | |
Operating CF per Share |
0.16 | 0.13 | 0.16 | 0.03 | |
Capex per Share |
(0.03) | 0.00 | (0.02) | (0.03) | |
Free Cash Flow per Share |
0.13 | 0.13 | 0.14 | 0.00 | |
Cash per Share |
1.04 | 1.02 | 0.93 | 0.81 | |
Shareholders Equity per Share |
1.76 | 1.72 | 1.92 | 1.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.76 | 1.72 | 1.92 | 1.84 | |
Free Cash Flow |
17.02 | 18.25 | 19.00 | (0.15) | |
Working Capital |
10.42 | 6.73 | 37.15 | 23.21 | |
Capital Expenditures |
(4.27) | 0.11 | (2.36) | (4.08) | |
Net Current Asset Value |
(104.32) | (112.00) | (84.46) | (98.71) | |
EV/EBIT |
581.74 | 0.00 | 69.48 | 0.00 | |
Capex to Sales |
0.02 | 0.00 | 0.01 | 0.02 | |
Price to Operating Income |
614.22 | 0.00 | 76.20 | 0.00 | |
| Other line items | |||||
Average Receivables |
42.67 | 39.85 | 38.85 | 38.27 | |
Average Payables |
96.05 | 90.38 | 56.97 | 48.32 | |
Average Assets |
542.12 | 542.02 | 526.13 | 518.98 | |
Average Common Equity |
238.33 | 239.19 | 258.76 | 259.44 |
Columns are period end dates